Stockbroking | Wealth Management | Corporate Advice


Resizing text on the web

To increase or decrease the magnification of a web page, press Ctrl and '+' (plus) to zoom in or Ctrl and '-' (minus) to zoom out. To return the page to its original size, press Ctrl + 0.

You can also scroll the mouse wheel up and down while holding Ctrl to increase/decrease zoom level.



Alex Lu

Key points

  • Orora's (ORA) FY17 result was broadly in line with our expectations but higher than Bloomberg consensus estimates.
  • Australiasia EBIT +2% and North America EBIT +23% (in USD terms).
  • Our FY18F EBIT remains unchanged while underlying NPAT rises 2% to A$199m.

FY17 result slightly ahead of expectations

FY17 underlying EBIT rose 11% to A$302.3m (+0% vs Morgans and +2% vs Bloomberg consensus), while underlying NPAT grew 14% to A$186.2m (+1% vs Morgans and +3% vs Bloomberg consensus). 

The result was driven by a strong performance from North America (EBIT +23% in USD), with Australasia (EBIT +7%) benefiting from ongoing delivery of self-help programs that more than offset input cost headwinds. The balance sheet remains strong with net debt/EBITDA falling 1.6x (FY16: 1.7x) and pleasingly, return on funds employed (ROFE) improved 90bps to 13.6%. Management remain confident they can increase ROFE to 15% over the next couple of years. We estimate ROFE to increase to 14.7% by FY19, and if achieved, will be a strong outcome given ROFE was 7.2% in FY13. 

Free cash flow (excl. one offs) was up 2% to A$215.5m and FY17 DPS of 11.0cps was slightly ahead of our forecast (10.4cps).

Plenty of capacity to pursue growth investments

FY17 ND/EBITDA at 1.6x remains well below management's 2-2.5x target range. While management's current focus is on integrating the recent acquisitions within Orora Visual and driving organic growth and implementing the ERP system within Orora Packaging Solutions (OPS), ORA's strong balance sheet gives it the flexibility to continue to pursue growth investments. Management said the pipeline for acquisitions remains healthy and there were also a number of organic growth initiatives that the company is pursuing. Given this healthy pipeline, capital management is not a priority at the moment. However, management did not rule out making a larger acquisition if the right one came along. Given the strong balance sheet, we estimate ORA has capacity to make a A$400m acquisition and still be within management's leverage target range.

Minor earnings forecast changes

Given the FY17 result was broadly in line with our expectations, we have made minimal changes to FY18-20F earnings. FY18F EBIT remains unchanged at A$322m while underlying NPAT rises 2% to A$199m due to lower net interest expense. We make similar adjustments to FY19 and FY20 forecasts.

Investment view

Given another solid result, we become increasingly confident in Orora's (ORA) ability to execute on its growth strategy. This is despite a number of input cost headwinds in the Australiasia business and, in our view, shows the strength of the underlying business and the quality of the management team.

We retain our Add recommendation.

More information

Morgans clients can login to view our detailed report and share price target for Orora (ORA). Alternatively, please contact your nearest Morgans office for access.

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.